Zhao W, Ma B, Tian Z, Han H, Tang J, Dong B, et al. Inhibiting CBX4 efficiently protects hepatocellular carcinoma cells against sorafenib resistance. Br J Cancer. 2021;124:1237.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fujita M, Yamaguchi R, Hasegawa T, Shimada S, Arihiro K, Hayashi S, et al. Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations. EBioMedicine. 2020;53:102659.
Article
PubMed
PubMed Central
Google Scholar
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.
Article
PubMed
Google Scholar
Zhang H, Dong P, Guo S, Tao C, Chen W, Zhao W, et al. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing. BMC Med. 2020;18(1):200.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gu X, Guan J, Xu J, Zheng Q, Chen C, Yang Q, et al. Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes. J Transl Med. 2021;19(1):26.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu S, Qiu J, He G, He W, Liu C, Cai D, et al. TRAIL promotes hepatocellular carcinoma apoptosis and inhibits proliferation and migration via interacting with IER3. Cancer Cell Int. 2021;21(1):63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Razavi ZS, Asgarpour K, Mahjoubin-Tehran M, Rasouli S, Khan H, Shahrzad MK, et al. Angiogenesis-related non-coding RNAs and gastrointestinal cancer. Mol Ther Oncol. 2021;21:220–41.
Article
Google Scholar
Shafabakhsh R, Arianfar F, Vosough M, Mirzaei HR, Mahjoubin-Tehran M, Khanbabaei H, et al. Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance. Cancer Gene Ther. 2021.
de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180–90.
Article
PubMed
Google Scholar
Tian MX, Liu WR, Wang H, Zhou YF, Jin L, Jiang XF, et al. Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma. BMC Med. 2019;17(1):106.
Article
PubMed
PubMed Central
Google Scholar
Zhou KQ, Sun YF, Cheng JW, Du M, Ji Y, Wang PX, et al. Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma. EBioMedicine. 2020;62:103107.
Article
PubMed
PubMed Central
Google Scholar
Zou Y, Li H, Graham ET, Deik AA, Eaton JK, Wang W, et al. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol. 2020;16(3):302–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang K, Wu Z, Si Y, Tang W, Xu X, Cheng Y, et al. Identification of LPCAT1 expression as a potential prognostic biomarker guiding treatment choice in acute myeloid leukemia. Oncol Lett. 2021;21(2):105.
Article
CAS
PubMed
Google Scholar
Jiang H, Li Z, Huan C, Jiang XC. Macrophage lysophosphatidylcholine acyltransferase 3 deficiency-mediated inflammation is not sufficient to induce atherosclerosis in a mouse model. Front Cardiovasc Med. 2018;5:192.
Article
CAS
PubMed
Google Scholar
Wang B, Tontonoz P. Phospholipid remodeling in physiology and disease. Annu Rev Physiol. 2019;81:165–88.
Article
PubMed
CAS
Google Scholar
Lebok P, von Hassel A, Meiners J, Hube-Magg C, Simon R, Höflmayer D, et al. Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer. Aging. 2019;11(18):7796–804.
Article
CAS
PubMed
PubMed Central
Google Scholar
Du Y, Wang Q, Zhang X, Wang X, Qin C, Sheng Z, et al. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma. J Exp Clin Cancer Res CR. 2017;36(1):66.
Article
PubMed
CAS
Google Scholar
Mansilla F, da Costa KA, Wang S, Kruhøffer M, Lewin TM, Orntoft TF, et al. Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer. J Mol Med (Berl). 2009;87(1):85–97.
Article
CAS
Google Scholar
Wei C, Dong X, Lu H, Tong F, Chen L, Zhang R, et al. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. J Exp Clin Cancer Res CR. 2019;38(1):95.
Article
PubMed
Google Scholar
Shida-Sakazume T, Endo-Sakamoto Y, Unozawa M, Fukumoto C, Shimada K, Kasamatsu A, et al. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor. PLoS ONE. 2015;10(3):e0120143.
Article
PubMed
PubMed Central
CAS
Google Scholar
Han C, Yu G, Mao Y, Song S, Li L, Zhou L, et al. LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production. PLoS ONE. 2020;15(11):e0240801.
Article
CAS
PubMed
PubMed Central
Google Scholar
Morita Y, Sakaguchi T, Ikegami K, Goto-Inoue N, Hayasaka T, Hang VT, et al. Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression. J Hepatol. 2013;59(2):292–9.
Article
CAS
PubMed
Google Scholar
Bi J, Ichu TA, Zanca C, Yang H, Zhang W, Gu Y, et al. Oncogene amplification in growth factor signaling pathways renders cancers dependent on membrane lipid remodeling. Cell Metab. 2019;30(3):525-38.e8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Han Y, Zhuang Q, Sun B, Lv W, Wang S, Xiao Q, et al. Crystal structure of steroid reductase SRD5A reveals conserved steroid reduction mechanism. Nat Commun. 2021;12(1):449.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bidar M, Bahlakeh A, Mahmoudi M, Ahrari F, Shahmohammadi R, Jafarzadeh H. Does the application of GaAlAs laser and platelet-rich plasma induce cell proliferation and increase alkaline phosphatase activity in human dental pulp stem cells? Lasers in medical science. 2021.
Wu HY, Cai KT, Ma J, Chen G, Dang YW, Lu HP, et al. Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: findings based on RT-qPCR and in silico analysis. Pathol Res Pract. 2019;215(7):152424.
Article
CAS
PubMed
Google Scholar
Xie Z, Dang Y, Wu H, He R, Ma J, Peng Z, et al. Effect of CELSR3 on the cell cycle and apoptosis of hepatocellular carcinoma cells. J Cancer. 2020;11(10):2830–44.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gao L, Yan SB, Yang J, Kong JL, Shi K, Ma FC, et al. MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip. BMC Med Genomics. 2020;13(1):3.
Article
PubMed
PubMed Central
CAS
Google Scholar
Gao L, Xiong DD, He RQ, Yang X, Lai ZF, Liu LM, et al. MIR22HG as a tumor suppressive lncRNA in HCC: a comprehensive analysis integrating RT-qPCR, mRNA-Seq, and microarrays. OncoTargets Ther. 2019;12:9827–48.
Article
CAS
Google Scholar
Itkonen HM, Urbanucci A, Martin SE, Khan A, Mathelier A, Thiede B, et al. High OGT activity is essential for MYC-driven proliferation of prostate cancer cells. Theranostics. 2019;9(8):2183–97.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou C, Liu C, Liu W, Chen W, Yin Y, Li CW, et al. SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway. Theranostics. 2020;10(10):4627–43.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nambiar DK, Aguilera T, Cao H, Kwok S, Kong C, Bloomstein J, et al. Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance. J Clin Invest. 2019;129(12):5553–67.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shan D, Zou L, Liu X, Shen Y, Cai Y, Zhang J. Efficacy and safety of gabapentin and pregabalin in patients with vasomotor symptoms: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;222(6):564-79.e12.
Article
CAS
PubMed
Google Scholar
Zhang L, Luo B, Dang YW, He RQ, Chen G, Peng ZG, et al. The clinical significance of endothelin receptor type B in hepatocellular carcinoma and its potential molecular mechanism. Exp Mol Pathol. 2019;107:141–57.
Article
CAS
PubMed
Google Scholar
Hong W, Yuan H, Gu Y, Liu M, Ji Y, Huang Z, et al. Immune-related prognosis biomarkers associated with osteosarcoma microenvironment. Cancer Cell Int. 2020;20:83.
Article
PubMed
PubMed Central
Google Scholar
Bi F, Chen Y, Yang Q. Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer. Cancer Cell Int. 2020;20:373.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kwon OS, Lee H, Kong HJ, Kwon EJ, Park JE, Lee W, et al. Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer. Oncogene. 2020;39(23):4567–80.
Article
CAS
PubMed
Google Scholar
Zhang C, Chen T, Li Z, Liu A, Xu Y, Gao Y, et al. Depiction of tumor stemlike features and underlying relationships with hazard immune infiltrations based on large prostate cancer cohorts. Briefings in bioinformatics. 2020.
Wang Y, Kong W, Wang L, Zhang T, Huang B, Meng J, et al. Multiple-purpose connectivity map analysis reveals the benefits of esculetin to hyperuricemia and renal fibrosis. Int J Mol Sci. 2020;21(20):7695.
Article
CAS
PubMed Central
Google Scholar
Liu Z, Wang X, Yang G, Zhong C, Zhang R, Ye J, et al. Construction of lncRNA-associated ceRNA networks to identify prognostic lncRNA biomarkers for glioblastoma. J Cell Biochem. 2020;121(7):3502–15.
Article
CAS
PubMed
Google Scholar
Ye G, Qin Y, Wang S, Pan D, Xu S, Wu C, et al. Lamc1 promotes the Warburg effect in hepatocellular carcinoma cells by regulating PKM2 expression through AKT pathway. Cancer Biol Ther. 2019;20(5):711–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li YL, Rao MJ, Zhang NY, Wu LW, Lin NM, Zhang C. BAY 87-2243 sensitizes hepatocellular carcinoma Hep3B cells to histone deacetylase inhibitors treatment via GSK-3β activation. Exp Ther Med. 2019;17(6):4547–53.
CAS
PubMed
PubMed Central
Google Scholar
Ferrín G, Guerrero M, Amado V, Rodríguez-Perálvarez M, De la Mata M. Activation of mTOR signaling pathway in hepatocellular carcinoma. Int J Mol Sci. 2020;21(4):1266.
Article
PubMed Central
CAS
Google Scholar
Li YL, Zhang NY, Hu X, Chen JL, Rao MJ, Wu LW, et al. Evodiamine induces apoptosis and promotes hepatocellular carcinoma cell death induced by vorinostat via downregulating HIF-1α under hypoxia. Biochem Biophys Res Commun. 2018;498(3):481–6.
Article
CAS
PubMed
Google Scholar
Miao JF, Peng YF, Chen S, Gao WJ, Yang QX, Zhu P, et al. A novel harmine derivative, N-(4-(hydroxycarbamoyl)benzyl)-1-(4-methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxamide (HBC), as histone deacetylase inhibitor: in vitro antiproliferation, apoptosis induction, cell cycle arrest, and antimetastatic effects. Eur J Pharmacol. 2018;824:78–88.
Article
CAS
PubMed
Google Scholar
Berndt N, Eckstein J, Heucke N, Gajowski R, Stockmann M, Meierhofer D, et al. Characterization of lipid and lipid droplet metabolism in human HCC. Cells. 2019;8(5):512.
Article
CAS
PubMed Central
Google Scholar
Sangineto M, Villani R, Cavallone F, Romano A, Loizzi D, Serviddio G. Lipid metabolism in development and progression of hepatocellular carcinoma. Cancers (Basel). 2020;12(6):1419.
Article
CAS
PubMed Central
Google Scholar
Tian Y, Yang B, Qiu W, Hao Y, Zhang Z, Yang B, et al. ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy. Nat Commun. 2019;10(1):3391.
Article
PubMed
PubMed Central
CAS
Google Scholar
Zhan T, Rindtorff N, Betge J, Ebert MP, Boutros M. CRISPR/Cas9 for cancer research and therapy. Semin Cancer Biol. 2019;55:106–19.
Article
CAS
PubMed
Google Scholar
Liu F, Wu Y, Liu J, Ni RJ, Yang AG, Bian K, et al. A miR-205-LPCAT1 axis contributes to proliferation and progression in multiple cancers. Biochem Biophys Res Commun. 2020;527(2):474–80.
Article
CAS
PubMed
Google Scholar
Zhao Y, Zhu C, Chang Q, Peng P, Yang J, Liu C, et al. MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7. PLoS ONE. 2020;15(11):e0242179.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhu M, Xu W, Wei C, Huang J, Xu J, Zhang Y, et al. CCL14 serves as a novel prognostic factor and tumor suppressor of HCC by modulating cell cycle and promoting apoptosis. Cell Death Dis. 2019;10(11):796.
Article
PubMed
PubMed Central
CAS
Google Scholar
Ying H, Ji L, Xu Z, Fan X, Tong Y, Liu H, et al. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B. Cancer Lett. 2020;473:13–24.
Article
CAS
PubMed
Google Scholar
Tian L, Yao K, Liu K, Han B, Dong H, Zhao W, et al. PLK1/NF-κB feedforward circuit antagonizes the mono-ADP-ribosyltransferase activity of PARP10 and facilitates HCC progression. Oncogene. 2020;39(15):3145–62.
Article
CAS
PubMed
Google Scholar
Xie B, Wang S, Jiang N, Li JJ. Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance. Cancer Lett. 2019;443:56–66.
Article
CAS
PubMed
Google Scholar
Willis L, Jönsson H, Huang KC. Limits and constraints on mechanisms of cell-cycle regulation imposed by cell size-homeostasis measurements. Cell Rep. 2020;32(6):107992.
Article
CAS
PubMed
Google Scholar
Sun J, Zhu Z, Li W, Shen M, Cao C, Sun Q, et al. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation. J Exp Clin Cancer Res CR. 2020;39(1):222.
Article
PubMed
CAS
Google Scholar
Jia M, Peng Z, Yang K, Su C, Wang Y, Yan C. A high-throughput targeted metabolomics method for the quantification of 104 non-polar metabolites in cholesterol, eicosanoid, and phospholipid metabolism: application in the study of a CCl(4)-induced liver injury mouse model. Analyst. 2020;145(10):3575–91.
Article
CAS
PubMed
Google Scholar
Sarvizadeh M, Hasanpour O, Naderi Ghale-Noie Z, Mollazadeh S, Rezaei M, Pourghadamyari H, et al. Allicin and digestive system cancers: from chemical structure to its therapeutic opportunities. Front Oncol. 2021;11:650256.
Article
PubMed
PubMed Central
Google Scholar
Zhang X, Shao J, Li X, Cui L, Tan Z. Docetaxel promotes cell apoptosis and decreases SOX2 expression in CD133-expressing hepatocellular carcinoma stem cells by suppressing the PI3K/AKT signaling pathway. Oncol Rep. 2019;41(2):1067–74.
CAS
PubMed
Google Scholar
Tsilimigras DI, Ntanasis-Stathopoulos I, Moris D, Spartalis E, Pawlik TM. Histone deacetylase inhibitors in hepatocellular carcinoma: a therapeutic perspective. Surg Oncol. 2018;27(4):611–8.
Article
PubMed
Google Scholar
Zhou L, Pan LC, Zheng YG, Du GS, Fu XQ, Zhu ZD, et al. Novel strategy of sirolimus plus thymalfasin and huaier granule on tumor recurrence of hepatocellular carcinoma beyond the UCSF criteria following liver transplantation: a single center experience. Oncol Lett. 2018;16(4):4407–17.
PubMed
PubMed Central
Google Scholar